Validity index of ultrasonography findings, fine needle aspiration cytology, PSA and DRE in patients suspicious for prostate cancer
Researcher Bulletin of Medical Sciences,
Vol. 28 No. 1 (2023),
9 January 2024
,
Page e2
Abstract
Background and Objective: Prompt diagnosis and treatment of prostate cancer is important to improve the prognosis. Hence in this study the role of radiology and FNA were compared for diagnosis of prostate cancer.
Materials and Methods: In this correlational-descriptive comparative study, 100 patients suspected to have prostate cancer were assessed. The results of FNA and radiology were compared.
Results: The final diagnosis was BPH in 68%, prostatitis in 24% and malignancy in 8%. Sensitivity and specificity of fine needle aspiration (FNA) were calculated respectively 100% and 90.22%, for ultrasonography 100% and 69.57%, for digital rectal exam (DRE) 75% and 58.7% finally for prostate serum antigen (PSA) 87% and 55%.
Conclusions: In general, we found out FNA has the highest validity index but regarding the invasive nature of the test it is not the primary exam to assess the patients. The high false positive cases found by PSA suggests that it may be a suitable screening test but not a reliable diagnostic one to find the patients with cancer.
- Prostate; Malignancy; Diagnosis
How to Cite
References
Gilliland F, Becker TM, Smith A, Key CR, Samet JM. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening. Cancer Epidemiol Biomarkers Prev. 1994 Mar;3(2):105-11.
Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009 Oct 21;302(15):1685-92.
Tenke P, Horti J, Balint P, Kovacs B. Prostate cancer screening. Recent Results Cancer Res. 2007; 175:65-81.
Zenger M, Hinz A, Stolzenburg JU, Rabenalt R, Schwalenberg T, Schwarz R. Health-related quality of life of prostate cancer patients compared to the general German population: age-specific results. Urol Int. 2009;83(2):166-70.
Krahn MD, Zagorski B, Laporte A, et al. Healthcare costs associated with prostate cancer: estimates from a population-based study. BJU Int. 2010 Feb;105(3):338-46.
Ghafoori M, Alizadeh M, Kuhpayehzade J. The value of diffusion weighted Magnetic Resonance Imaging in diagnosis of prostate cancer. Tehran Univ Med J. 2013; 71 (6) :351-5.
Hermida Pérez JA, Ochoa Urdangarain O, Ramos Rodríguez AV, Acosta Bernad I, Vento Remedios T, Mesa Borroto D, https://www.ncbi.nlm.nih.gov/pubmed/?term=L%C3%B3pez%20Rivero%20A%5BAuthor%5D&cauthor=true&cauthor_uid=11296669et al. Fine-needle aspiration cytology in the diagnosis of prostate cancer. Results. Arch Esp Urol. 2001 Jan-Feb;54(1):23-33.
Saleh AF, Nahar Rahman AJ, Salam MA, Islam F. Role of fine needle aspiration cytology (FNAC) in the diagnosis of prostatic lesions with histologic correlation. Bangladesh Med Res Counc Bull. 2005 Dec;31(3):95-103.
Polito M, Alberti R, Muzzonigro G, Baldi A, Diambrini M, Vecchi A. Fine needle aspiration biopsy of the prostate gland: our experience concerning 101 cases with histological follow-up. Prostate. 1990;17(2):85-94.
Brenner DW, Ladaga LE, Fillion MB, Schlossberg SM, Schellhammer PF. Comparison of transrectal fine-needle aspiration cytology and core needle biopsy in diagnosis of prostate cancer. Urology. 1990 May;35(5):381-4.
Weidner A, Michaely HJ, Pelzer A, Michel MS, Wenz F, Schoenberg SO,https://www.ncbi.nlm.nih.gov/pubmed/?term=Dinter%20DJ%5BAuthor%5D&cauthor=true&cauthor_uid=20101785et al. Imaging of prostate cancer by diagnostic radiology and nuclear medicine. Aktuelle Urol. 2010 Jan;41(1):35-42.
Harvey H, deSouza NM. The role of imaging in the diagnosis of primary prostate cancer. J Clin Urol. 2016 Dec;9(2 Suppl):11-7.
- Abstract Viewed: 174 times